Associate Director, Safety Science, Japan
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Associate Director, Safety Science, Japan is responsible for providing safety science and pharmacovigilance expertise to safety management with the assigned products across the RevMed portfolio in Japan. The individual will be responsible for conducting safety signal detection and evaluation, contribution to clinical safety oversight, and leading development and maintenance of Japan Risk Management Plans (J-RMPs), and other safety management activities in accordance with applicable Japanese regulations, such as GV
